These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15107899)

  • 21. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.
    Strang J; Gossop M; Heuston J; Green J; Whiteley C; Maden A
    Addiction; 2006 Aug; 101(8):1125-32. PubMed ID: 16869842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual dollar expenditure and earnings from cannabis in the New Zealand population.
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2007 May; 18(3):187-93. PubMed ID: 17689365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal methamphetamine: a source of added sexual risk for Hispanic men who have sex with men?
    Fernández MI; Bowen GS; Warren JC; Ibañez GE; Hernandez N; Harper GW; Prado G
    Drug Alcohol Depend; 2007 Jan; 86(2-3):245-52. PubMed ID: 16930858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study.
    Degenhardt L; Coffey C; Moran P; Carlin JB; Patton GC
    Addiction; 2007 Jul; 102(7):1076-84. PubMed ID: 17567396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug use patterns and mental health of regular amphetamine users during a reported 'heroin drought'.
    Baker A; Lee NK; Claire M; Lewin TJ; Grant T; Pohlman S; Saunders JB; Kay-Lambkin F; Constable P; Jenner L; Carr VJ
    Addiction; 2004 Jul; 99(7):875-84. PubMed ID: 15200583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men.
    Semple SJ; Patterson TL; Grant I
    Drug Alcohol Depend; 2004 Nov; 76(2):203-12. PubMed ID: 15488344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marijuana use in New Zealand, 1990 and 1998.
    Field A; Casswell S
    N Z Med J; 2001 Aug; 114(1137):355-8. PubMed ID: 11587304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.
    Verschraagen M; Maes A; Ruiter B; Bosman IJ; Smink BE; Lusthof KJ
    Forensic Sci Int; 2007 Aug; 170(2-3):163-70. PubMed ID: 17658708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain?
    Lee MO; Vivier PM; Diercks DB
    J Emerg Med; 2009 Aug; 37(2):237-41. PubMed ID: 19081702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of crystal methamphetamine among gay men in London.
    Bolding G; Hart G; Sherr L; Elford J
    Addiction; 2006 Nov; 101(11):1622-30. PubMed ID: 17034442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol and drug treatment population profile: a comparison of 1998 and 2004 data in New Zealand.
    Adamson S; Sellman D; Deering D; Robertson P; de Zwart K
    N Z Med J; 2006 Oct; 119(1244):U2284. PubMed ID: 17072359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development and initial validation of a questionnaire to measure craving for amphetamine.
    James D; Davies G; Willner P
    Addiction; 2004 Sep; 99(9):1181-8. PubMed ID: 15317639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamines in washed hair of demonstrated users and workplace subjects.
    Cairns T; Hill V; Schaffer M; Thistle W
    Forensic Sci Int; 2004 Oct; 145(2-3):137-42. PubMed ID: 15451085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation?
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2010 Jan; 21(1):86-90. PubMed ID: 19359158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.